Announcements
- Life Science Cares Launches in Switzerland
- Molecular Partners Announces All Board Proposals Approved at the Annual General Meeting
- Molecular Partners Publishes Invitation to Annual General Meeting 2024
- Molecular Partners Reports Corporate Highlights From Q4 2023 and Key Financials for Full Year 2023
- Molecular Partners Announces Dismissal of Class Action Lawsuit
- Molecular Partners To Hold Conference Call to Discuss Fourth Quarter and Full Year 2023 Results and Announces Upcoming Investor Presentations
- Molecular Partners Presents Positive Initial Data from First Four Dosing Cohorts of Ongoing Phase 1/2a Trial of MP0533 for Patients with Relapsed/Refractory AML and AML/MDS at ASH Annual Meeting
More ▼
Key statistics
On Friday, Molecular Partners AG (6ML0:STU) closed at 3.40, 44.07% above the 52 week low of 2.36 set on Jun 20, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.36 |
---|---|
High | 3.44 |
Low | 3.34 |
Bid | 3.28 |
Offer | 3.46 |
Previous close | 3.42 |
Average volume | 0.00 |
---|---|
Shares outstanding | 36.37m |
Free float | 32.85m |
P/E (TTM) | -- |
Market cap | 133.80m USD |
EPS (TTM) | -2.07 USD |
Data delayed at least 15 minutes, as of Apr 19 2024.
More ▼